DsbA: A target for the design of drug candidates as selective inhibitors of oxidative protein folding in Gram-negative bacteria

  • Scanlon, Martin (Primary Chief Investigator (PCI))
  • Charman, William (Chief Investigator (CI))
  • Sakellaris, Haralambos, (Chief Investigator (CI))
  • Farrell, Leigh (Partner Investigator (PI))

Project: Research

StatusFinished
Effective start/end date3/02/051/02/07

Funding

  • Australian Research Council (ARC): AUD104,450.00
  • GBS Ventures: AUD90,000.00